Breye Therapeutics raised €68M in a Series A round in Oct 2026. The company is based in Copenhagen, Denmark. Investors in the round: Catalyze Capital, EIFO, Innovestor Life Science Fund and 6 others. Data as of 2 Oct 2026.
Reported in EUR — no conversion. €68M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
